de Kroon CD - Search Results

1

FoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinoma.

Punt S, van Vliet ME, Spaans VM, de Kroon CD, Fleuren GJ, Gorter A, Jordanova ES. Punt S, et al. Among authors: de kroon cd. Cancer Immunol Immunother. 2015 Jun;64(6):745-53. doi: 10.1007/s00262-015-1678-4. Epub 2015 Mar 21. Cancer Immunol Immunother. 2015. PMID: 25795131 Free PMC article.

2

Correlations between immune response and vascularization qRT-PCR gene expression clusters in squamous cervical cancer.

Punt S, Houwing-Duistermaat JJ, Schulkens IA, Thijssen VL, Osse EM, de Kroon CD, Griffioen AW, Fleuren GJ, Gorter A, Jordanova ES. Punt S, et al. Among authors: de kroon cd. Mol Cancer. 2015 Mar 31;14:71. doi: 10.1186/s12943-015-0350-0. Mol Cancer. 2015. PMID: 25889974 Free PMC article.

3

Galectin-1, -3 and -9 Expression and Clinical Significance in Squamous Cervical Cancer.

Punt S, Thijssen VL, Vrolijk J, de Kroon CD, Gorter A, Jordanova ES. Punt S, et al. Among authors: de kroon cd. PLoS One. 2015 Jun 12;10(6):e0129119. doi: 10.1371/journal.pone.0129119. eCollection 2015. PLoS One. 2015. PMID: 26066796 Free PMC article.

4

Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival.

Punt S, Corver WE, van der Zeeuw SA, Kielbasa SM, Osse EM, Buermans HP, de Kroon CD, Jordanova ES, Gorter A. Punt S, et al. Among authors: de kroon cd. Oncotarget. 2015 Nov 17;6(36):38681-94. doi: 10.18632/oncotarget.4526. Oncotarget. 2015. PMID: 26299617 Free PMC article.

5

L1 cell adhesion molecule (L1CAM) is a strong predictor for locoregional recurrences in cervical cancer.

Schrevel M, Corver WE, Vegter ME, Ter Haar NT, Dreef EJ, Beltman JJ, Kenter G, Bosse T, de Kroon CD, Jordanova ES. Schrevel M, et al. Among authors: de kroon cd. Oncotarget. 2017 Sep 18;8(50):87568-87581. doi: 10.18632/oncotarget.20976. eCollection 2017 Oct 20. Oncotarget. 2017. PMID: 29152102 Free PMC article.

6

Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer.

Heeren AM, van Luijk IF, Lakeman J, Pocorni N, Kole J, de Menezes RX, Kenter GG, Bosse T, de Kroon CD, Jordanova ES. Heeren AM, et al. Among authors: de kroon cd, de menezes rx. Cancer Immunol Immunother. 2019 Nov;68(11):1759-1767. doi: 10.1007/s00262-019-02412-x. Epub 2019 Oct 15. Cancer Immunol Immunother. 2019. PMID: 31616965 Free PMC article.

7

Nerve sparing in radical surgery for early-stage cervical cancer: yes we should!

de Kroon CD, Gaarenstroom KN, van Poelgeest MI, Peters AA, Trimbos JB. de Kroon CD, et al. Int J Gynecol Cancer. 2010 Oct;20(11 Suppl 2):S39-41. doi: 10.1111/IGC.0b013e3181f6381f. Int J Gynecol Cancer. 2010. PMID: 20975361 Review.

8

Randomized comparison of near-infrared fluorescence lymphatic tracers for sentinel lymph node mapping of cervical cancer.

Schaafsma BE, van der Vorst JR, Gaarenstroom KN, Peters AA, Verbeek FP, de Kroon CD, Trimbos JB, van Poelgeest MI, Frangioni JV, van de Velde CJ, Vahrmeijer AL. Schaafsma BE, et al. Among authors: de kroon cd. Gynecol Oncol. 2012 Oct;127(1):126-30. doi: 10.1016/j.ygyno.2012.07.002. Epub 2012 Jul 10. Gynecol Oncol. 2012. PMID: 22796548 Free PMC article. Clinical Trial.

9

Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.

Krämer P, Talhouk A, Brett MA, Chiu DS, Cairns ES, Scheunhage DA, Hammond RFL, Farnell D, Nazeran TM, Grube M, Xia Z, Senz J, Leung S, Feil L, Pasternak J, Dixon K, Hartkopf A, Krämer B, Brucker S, Heitz F, du Bois A, Harter P, Kommoss FKF, Sinn HP, Heublein S, Kommoss F, Vollert HW, Manchanda R, de Kroon CD, Nijman HW, de Bruyn M, Thompson EF, Bashashati A, McAlpine JN, Singh N, Tinker AV, Staebler A, Bosse T, Kommoss S, Köbel M, Anglesio MS. Krämer P, et al. Among authors: de bruyn m, de kroon cd. Clin Cancer Res. 2020 Oct 15;26(20):5400-5410. doi: 10.1158/1078-0432.CCR-20-1268. Epub 2020 Jul 31. Clin Cancer Res. 2020. PMID: 32737030

10

Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity.

de Jonge MM, Ritterhouse LL, de Kroon CD, Vreeswijk MPG, Segal JP, Puranik R, Hollema H, Rookus MA, van Asperen CJ, van Leeuwen FE, Smit VTHBM, Howitt BE, Bosse T; HEBON Group. de Jonge MM, et al. Among authors: de kroon cd. Clin Cancer Res. 2019 Dec 15;25(24):7517-7526. doi: 10.1158/1078-0432.CCR-19-0848. Epub 2019 Sep 6. Clin Cancer Res. 2019. PMID: 31492746

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

94 results

Search Page